BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8896415)

  • 1. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations.
    Khanim F; Yao QY; Niedobitek G; Sihota S; Rickinson AB; Young LS
    Blood; 1996 Nov; 88(9):3491-501. PubMed ID: 8896415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease.
    Dolcetti R; Zancai P; De Re V; Gloghini A; Bigoni B; Pivetta B; De Vita S; Carbone A; Boiocchi M
    Blood; 1997 Mar; 89(5):1723-31. PubMed ID: 9057656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
    Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein--Barr virus gene polymorphisms in Chinese Hodgkin's disease cases and healthy donors: identification of three distinct virus variants.
    Zhou XG; Sandvej K; Li PJ; Ji XL; Yan QH; Zhang XP; Da JP; Hamilton-Dutoit SJ
    J Gen Virol; 2001 May; 82(Pt 5):1157-1167. PubMed ID: 11297690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary non-Hodgkin's lymphoma of the intestine: high prevalence of Epstein-Barr virus in Mexican lymphomas as compared with European cases.
    Quintanilla-Martínez L; Lome-Maldonado C; Ott G; Gschwendtner A; Gredler E; Reyes E; Angeles-Angeles A; Fend F
    Blood; 1997 Jan; 89(2):644-51. PubMed ID: 9002968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China.
    Sung NS; Edwards RH; Seillier-Moiseiwitsch F; Perkins AG; Zeng Y; Raab-Traub N
    Int J Cancer; 1998 Apr; 76(2):207-15. PubMed ID: 9537582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers.
    Fischer N; Kopper B; Graf N; Schlehofer JR; Grässer FA; Mueller-Lantzsch N
    Virus Res; 1999 Mar; 60(1):41-54. PubMed ID: 10225273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
    Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
    J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: high frequency of a 30-bp deletion.
    Hayashi K; Chen WG; Chen YY; Bacchi MM; Bacchi CE; Alvarenga M; Abreu ES; Chang KL; Weiss LM
    Hum Pathol; 1997 Dec; 28(12):1408-14. PubMed ID: 9416698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of an Epstein-Barr-virus variant in T-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population.
    Chang YS; Su IJ; Chung PJ; Shu CH; Ng CK; Wu SJ; Liu ST
    Int J Cancer; 1995 Sep; 62(6):673-7. PubMed ID: 7558413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
    Knecht H; Martius F; Bachmann E; Hoffman T; Zimmermann DR; Rothenberger S; Sandvej K; Wegmann W; Hurwitz N; Odermatt BF
    Leukemia; 1995 Mar; 9(3):458-65. PubMed ID: 7885044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pathologic study of Hodgkin's disease in Korea and its association with Epstein-Barr virus infection.
    Huh J; Park C; Juhng S; Kim CE; Poppema S; Kim C
    Cancer; 1996 Mar; 77(5):949-55. PubMed ID: 8608489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin].
    Yakovleva LS; Senyuta NB; Goncharova EV; Scherback LN; Smirnova RV; Pavlish OA; Gurtsevitch VE
    Mol Biol (Mosk); 2015; 49(5):800-10. PubMed ID: 26510598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue.
    Dirnhofer S; Angeles-Angeles A; Ortiz-Hidalgo C; Reyes E; Gredler E; Krugmann J; Fend F; Quintanilla-Martinez L
    Hum Pathol; 1999 Jul; 30(7):781-7. PubMed ID: 10414496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric Hodgkin's disease in Spain: association with Epstein-Barr virus strains carrying latent membrane protein-1 oncogene deletions and high frequency of dual infections.
    Santón A; Martín C; Manzanal AI; Preciado MV; Bellas C
    Br J Haematol; 1998 Oct; 103(1):129-36. PubMed ID: 9792299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains.
    Edwards RH; Seillier-Moiseiwitsch F; Raab-Traub N
    Virology; 1999 Aug; 261(1):79-95. PubMed ID: 10441557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational events in LMP1 gene of Epstein-Barr virus in salivary gland lymphoepithelial carcinomas.
    Jen KY; Cheng J; Li J; Wu L; Li Y; Yu S; Lin H; Chen Z; Gurtsevitch V; Saku T
    Int J Cancer; 2003 Jul; 105(5):654-60. PubMed ID: 12740914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
    Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS
    Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas.
    Sandvej K; Peh SC; Andresen BS; Pallesen G
    Blood; 1994 Dec; 84(12):4053-60. PubMed ID: 7994023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of Epstein-Barr virus gene polymorphisms in nasal T/NK-cell lymphomas and normal nasal tissues: implications on virus strain selection in malignancy.
    Chiang AK; Wong KY; Liang AC; Srivastava G
    Int J Cancer; 1999 Jan; 80(3):356-64. PubMed ID: 9935174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.